Nosocomial Infections – A Growing Problem

Flexi-Seal^TM FMS is a closed system designed to minimize the spread of infection by containing infectious liquid/semi-liquid stool.

It has been scientifically proven in-vitro to contain the spread of C. difficile.¹ The closed system may help to reduce environmental contamination from other potentially pathogenic bacteria such as extended-spectrum beta-lactamase (ESBL) producing bacteria and methicillin-resistant Staphylococus aureus (MRSA).

Help reduce complications and cut costs

Nosocomial infections are a common complication of hospitalization and are associated with higher rates of morbidity and mortality.² These infections lead to extended hospital stays and an increase in treatment and diagnostics that result in increased costs.³,⁴

• Infection-related costs can exceed $13,675 per case.⁵
• Increases length of stay by 3.6 days per patient.⁶
• Up to 20% of hospitalized patients can become infected with C. difficile with a considerable impact on length of stay.⁶